Oruka Therapeutics, Inc. Accrued Liabilities and Other Liabilities
Oruka Therapeutics, Inc. (ORKA) had Accrued Liabilities and Other Liabilities of $14.35 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2026-08-10
- 2026-06-30: Accrued Liabilities and Other Liabilities $14.35M.
- 2026-03-31: Accrued Liabilities and Other Liabilities $9.29M.
- 2025-12-31: Accrued Liabilities and Other Liabilities $10.59M.
- 2025-09-30: Accrued Liabilities and Other Liabilities $8.65M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2026-06-30 | $14.35M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $9.29M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $10.59M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $8.65M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.58M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $5.66M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $3.35M 10-K · filed 2026-03-12 |
| 2024-09-30 | $1.71M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |